FineMark National Bank & Trust’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $16.7M | Sell |
15,517
-39
| -0.3% | -$37.3K | 0.52% | 50 |
|
|
2025
Q3 | $11.9M | Sell |
15,556
-1,399
| -8% | -$1.04M | 0.39% | 67 |
|
|
2025
Q2 | $13.2M | Sell |
16,955
-1,706
| -9% | -$1.33M | 0.45% | 64 |
|
|
2025
Q1 | $15.4M | Buy |
18,661
+697
| +4% | +$580K | 0.56% | 52 |
|
|
2024
Q4 | $13.9M | Buy |
17,964
+43
| +0.2% | +$35.6K | 0.48% | 59 |
|
|
2024
Q3 | $15.9M | Sell |
17,921
-729
| -4% | -$655K | 0.55% | 54 |
|
|
2024
Q2 | $16.9M | Sell |
18,650
-536
| -3% | -$429K | 0.62% | 44 |
|
|
2024
Q1 | $14.9M | Sell |
19,186
-505
| -3% | -$359K | 0.55% | 50 |
|
|
2023
Q4 | $11.5M | Sell |
19,691
-38
| -0.2% | -$22.2K | 0.47% | 62 |
|
|
2023
Q3 | $10.6M | Buy |
19,729
+234
| +1% | +$121K | 0.46% | 63 |
|
|
2023
Q2 | $9.14M | Buy |
19,495
+607
| +3% | +$255K | 0.38% | 73 |
|
|
2023
Q1 | $6.49M | Sell |
18,888
-1,453
| -7% | -$490K | 0.28% | 85 |
|
|
2022
Q4 | $7.44M | Sell |
20,341
-719
| -3% | -$255K | 0.33% | 77 |
|
|
2022
Q3 | $6.81M | Sell |
21,060
-1,027
| -5% | -$325K | 0.33% | 78 |
|
|
2022
Q2 | $7.16M | Sell |
22,087
-452
| -2% | -$136K | 0.32% | 80 |
|
|
2022
Q1 | $6.45M | Buy |
22,539
+59
| +0.3% | +$15.2K | 0.26% | 90 |
|
|
2021
Q4 | $6.21M | Sell |
22,480
-1,283
| -5% | -$325K | 0.23% | 93 |
|
|
2021
Q3 | $5.49M | Buy |
23,763
+921
| +4% | +$227K | 0.23% | 95 |
|
|
2021
Q2 | $5.24M | Sell |
22,842
-847
| -4% | -$170K | 0.21% | 101 |
|
|
2021
Q1 | $4.43M | Sell |
23,689
-313
| -1% | -$61.2K | 0.19% | 106 |
|
|
2020
Q4 | $4.05M | Buy |
24,002
+8
| +0% | +$1.19K | 0.18% | 100 |
|
|
2020
Q3 | $3.55M | Sell |
23,994
-127
| -0.5% | -$19.7K | 0.17% | 97 |
|
|
2020
Q2 | $3.96M | Sell |
24,121
-694
| -3% | -$107K | 0.22% | 91 |
|
|
2020
Q1 | $3.44M | Sell |
24,815
-518
| -2% | -$71.2K | 0.22% | 91 |
|
|
2019
Q4 | $3.33M | Sell |
25,333
-205
| -0.8% | -$23.8K | 0.17% | 104 |
|
|
2019
Q3 | $2.86M | Buy |
25,538
+508
| +2% | +$56.6K | 0.15% | 108 |
|
|
2019
Q2 | $2.77M | Sell |
25,030
-590
| -2% | -$69.5K | 0.15% | 107 |
|
|
2019
Q1 | $3.32M | Sell |
25,620
-2,625
| -9% | -$319K | 0.19% | 99 |
|
|
2018
Q4 | $3.27M | Sell |
28,245
-975
| -3% | -$109K | 0.22% | 90 |
|
|
2018
Q3 | $3.14M | Sell |
29,220
-1,902
| -6% | -$190K | 0.19% | 97 |
|
|
2018
Q2 | $2.66M | Buy |
31,122
+914
| +3% | +$75.1K | 0.16% | 108 |
|
|
2018
Q1 | $2.34M | Buy |
30,208
+1,934
| +7% | +$156K | 0.15% | 109 |
|
|
2017
Q4 | $2.39M | Sell |
28,274
-257
| -0.9% | -$21.9K | 0.15% | 110 |
|
|
2017
Q3 | $2.44M | Sell |
28,531
-928
| -3% | -$76.1K | 0.16% | 107 |
|
|
2017
Q2 | $2.42M | Sell |
29,459
-851
| -3% | -$69.4K | 0.17% | 106 |
|
|
2017
Q1 | $2.55M | Buy |
30,310
+943
| +3% | +$75.5K | 0.19% | 107 |
|
|
2016
Q4 | $2.16M | Buy |
29,367
+1,329
| +5% | +$99K | 0.17% | 107 |
|
|
2016
Q3 | $2.25M | Buy |
28,038
+251
| +0.9% | +$20.1K | 0.24% | 100 |
|
|
2016
Q2 | $2.19M | Buy |
27,787
+138
| +0.5% | +$10.4K | 0.24% | 95 |
|
|
2016
Q1 | $1.99M | Buy |
27,649
+1,257
| +5% | +$95.1K | 0.23% | 101 |
|
|
2015
Q4 | $2.22M | Buy |
26,392
+246
| +0.9% | +$20.4K | 0.27% | 94 |
|
|
2015
Q3 | $2.19M | Sell |
26,146
-1,904
| -7% | -$161K | 0.3% | 87 |
|
|
2015
Q2 | $2.34M | Sell |
28,050
-1,194
| -4% | -$91K | 0.31% | 88 |
|
|
2015
Q1 | $2.13M | Sell |
29,244
-2,151
| -7% | -$153K | 0.29% | 94 |
|
|
2014
Q4 | $2.17M | Sell |
31,395
-696
| -2% | -$47K | 0.32% | 86 |
|
|
2014
Q3 | $2.08M | Buy |
32,091
+2,197
| +7% | +$139K | 0.33% | 84 |
|
|
2014
Q2 | $1.86M | Buy |
29,894
+4,341
| +17% | +$259K | 0.31% | 85 |
|
|
2014
Q1 | $1.5M | Sell |
25,553
-3,062
| -11% | -$171K | 0.28% | 95 |
|
|
2013
Q4 | $1.46M | Buy |
28,615
+3,749
| +15% | +$188K | 0.3% | 92 |
|
|
2013
Q3 | $1.25M | Buy |
24,866
+7,317
| +42% | +$383K | 0.31% | 85 |
|
|
2013
Q2 | $862K | Buy |
+17,549
| New | +$955K | 0.26% | 84 |
|
Other funds holding LLY
FineMark National Bank & Trust's LLY Position: Q4 2025 in Review
FineMark National Bank & Trust reduced its Eli Lilly (LLY) stake by 0.25% in Q4 2025, selling an estimated $37.3K and leaving 15,517 shares worth $16.7M. The position accounts for 0.52% of the portfolio, ranked #50.
FineMark National Bank & Trust first reported a position in LLY in Q2 2013 and has held it in 51 quarters since. The position peaked at $16.9M in Q2 2024. 4,428 funds tracked by Wall St. Rank hold LLY as of Q4 2025.
- FineMark National Bank & Trust held 15,517 shares of Eli Lilly worth $16.7M as of Q4 2025.
- FineMark National Bank & Trust sold 39 Eli Lilly shares in Q4 2025, an estimated $37.3K.
- Eli Lilly made up 0.52% of FineMark National Bank & Trust's portfolio in Q4 2025, its #50 holding.
- FineMark National Bank & Trust first reported a position in Eli Lilly in Q2 2013 and has held it in 51 quarters since.
- FineMark National Bank & Trust's Eli Lilly position peaked at $16.9M in Q2 2024.
- 4,428 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.
Based on FineMark National Bank & Trust's 13F filing for Q4 2025, filed 12 Feb 2026.